Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.465
+0.035 (2.45%)
Jun 22, 2026, 12:35 PM EDT - Market open
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $32.91 million as of June 22, 2026. Its market cap has increased by 25.65% in one year.
Market Cap
32.91M
Enterprise Value
-11.76M
1-Year Change
25.65%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $32.91M, a decrease of -90.75%. That is a compound annual growth rate of -65.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 32.91M | 22.51% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GridAI Technologies | 35.93M |
| Nutriband | 35.25M |
| ABVC BioPharma | 34.11M |
| Aligos Therapeutics | 32.67M |
| Daré Bioscience | 32.51M |
| Actinium Pharmaceuticals | 32.32M |
| Lisata Therapeutics | 32.05M |
| NanoViricides | 31.89M |